INKON Life Technology Co Ltd (300143) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.052x

Based on the latest financial reports, INKON Life Technology Co Ltd (300143) has a cash flow conversion efficiency ratio of 0.052x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥71.76 Million ≈ $10.50 Million USD) by net assets (CN¥1.38 Billion ≈ $201.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

INKON Life Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how INKON Life Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read INKON Life Technology Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

INKON Life Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of INKON Life Technology Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Under Armour Inc C
NYSE:UA
0.194x
YFY Inc
TW:1907
0.038x
G-III Apparel Group Ltd
NASDAQ:GIII
-0.054x
Sichuan Chuanhuan Technology Co Ltd
SHE:300547
-0.006x
Suzhou Chunqiu Electronic Technology Co Ltd Class A
SHG:603890
0.028x
Treehouse Foods Inc
NYSE:THS
0.030x
Biotage AB
ST:BIOT
0.011x
Henan Yicheng New Energy Co Ltd
SHE:300080
-0.017x

Annual Cash Flow Conversion Efficiency for INKON Life Technology Co Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of INKON Life Technology Co Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of INKON Life Technology Co Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.48 Billion
≈ $362.66 Million
CN¥259.25 Million
≈ $37.94 Million
0.105x -21.34%
2023-12-31 CN¥1.43 Billion
≈ $209.08 Million
CN¥190.01 Million
≈ $27.80 Million
0.133x +9.04%
2022-12-31 CN¥1.32 Billion
≈ $192.77 Million
CN¥160.67 Million
≈ $23.51 Million
0.122x +75.31%
2021-12-31 CN¥1.81 Billion
≈ $264.20 Million
CN¥125.61 Million
≈ $18.38 Million
0.070x +83.91%
2020-12-31 CN¥2.24 Billion
≈ $327.88 Million
CN¥84.77 Million
≈ $12.40 Million
0.038x +73.71%
2019-12-31 CN¥1.37 Billion
≈ $200.10 Million
CN¥29.78 Million
≈ $4.36 Million
0.022x -54.84%
2018-12-31 CN¥2.07 Billion
≈ $302.49 Million
CN¥99.69 Million
≈ $14.59 Million
0.048x -29.68%
2017-12-31 CN¥2.43 Billion
≈ $355.97 Million
CN¥166.82 Million
≈ $24.41 Million
0.069x +237.48%
2016-12-31 CN¥2.20 Billion
≈ $321.31 Million
CN¥44.62 Million
≈ $6.53 Million
0.020x -42.42%
2015-12-31 CN¥1.48 Billion
≈ $217.17 Million
CN¥52.37 Million
≈ $7.66 Million
0.035x -42.87%
2014-12-31 CN¥343.97 Million
≈ $50.33 Million
CN¥21.25 Million
≈ $3.11 Million
0.062x +192.22%
2013-12-31 CN¥643.30 Million
≈ $94.14 Million
CN¥13.60 Million
≈ $1.99 Million
0.021x -36.66%
2012-12-31 CN¥810.78 Million
≈ $118.64 Million
CN¥27.06 Million
≈ $3.96 Million
0.033x -71.28%
2011-12-31 CN¥785.85 Million
≈ $114.99 Million
CN¥91.32 Million
≈ $13.36 Million
0.116x +37.33%
2010-12-31 CN¥727.00 Million
≈ $106.38 Million
CN¥61.51 Million
≈ $9.00 Million
0.085x -61.27%
2009-12-31 CN¥116.90 Million
≈ $17.11 Million
CN¥25.54 Million
≈ $3.74 Million
0.218x -11.98%
2008-12-31 CN¥81.55 Million
≈ $11.93 Million
CN¥20.24 Million
≈ $2.96 Million
0.248x -41.95%
2007-12-31 CN¥74.89 Million
≈ $10.96 Million
CN¥32.02 Million
≈ $4.69 Million
0.428x --

About INKON Life Technology Co Ltd

SHE:300143 China Medical Devices
Market Cap
$1.23 Billion
CN¥8.43 Billion CNY
Market Cap Rank
#8217 Global
#2086 in China
Share Price
CN¥11.25
Change (1 day)
-0.09%
52-Week Range
CN¥8.99 - CN¥13.38
All Time High
CN¥29.11
About

INKON Life Technology Co., Ltd. focuses on building an ecological platform for chain of prevention / diagnosis / treatment / rehabilitation, providing medical services for tumors in China and internationally. It provides medical devices solution for radiotherapy, life support, image enhancement, and chronic disease treatment, as well as oncology medical services. The company was formerly known as… Read more